Stock Code: 06185 Stock Name: CanSino Biologics Inc.

In February 2026, CanSino Biologics Inc. reported that its total authorized share capital remained at RMB 247.04 million, including approximately 132.67 million H shares and 114.37 million A shares (both rounding to two decimals). There were no changes to the number of issued shares or treasury shares across H shares and A shares during the month. The H-share public float requirement was confirmed to be in compliance.

Under the 2025 Core Management H Share Option Scheme, 860,000 H share options remained outstanding throughout February 2026, with no new shares issued during the period. For the 2025 Restricted A Share Incentive Scheme, 2.05 million restricted A shares (rounded to two decimals) remained available for issuance, with no shares issued in February 2026.